Health Products

Rifadin

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
Lot 3099036A. Rifadin
Recalling Firm
Sanofi Aventis (Canada) Inc.
2905 Louis R. Renaud Place
Laval
H7V 0A3
Quebec
CANADA
Marketing Authorization Holder
Sanofi Aventis (Canada) Inc.
2905 Louis R. Renaud Place
Laval
H7V 0A3
Quebec
CANADA
CapsuleDIN 02091887150 mg / capsule

Introduction

Recalled Product

A. Rifadin

Reason

Manufacturer testing revealed out-of-specification fill weight results in retention samples for Rifadin 150mg capsules from batch 3099036.

Depth of distribution

Wholesalers and pharmacies
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime